Carcidiag Biotechnologies

About:

Carcidiag Biotechnologies is develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells.

Website: https://carcidiag.com/

Description:

Carcidiag Biotechnologies develops a diagnostic, fast, sensitive, specific and innovative tool for the detection of precancerous cells for the prevention of carcinogenesis affecting the ENT sphere (tongue, pharynx, oral mucosa), the colorectal area and the lungs as well as the gynecological cancers.

Total Funding Amount:

1M EUR

Headquarters Location:

Guéret, Limousin, France

Founded Date:

2017-01-01

Founders:

Christian Laurance, Vincent Carre

Number of Employees:

1-10

Last Funding Date:

2017-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai